Growth Metrics

Merck (MRK) Total Debt (2016 - 2026)

Merck has reported Total Debt over the past 18 years, most recently at $49.1 billion for Q1 2026.

  • Quarterly Total Debt rose 40.96% to $49.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $49.1 billion through Mar 2026, up 40.96% year-over-year, with the annual reading at $49.3 billion for FY2025, 32.95% up from the prior year.
  • Total Debt was $49.1 billion for Q1 2026 at Merck, roughly flat from $49.3 billion in the prior quarter.
  • Over five years, Total Debt peaked at $49.3 billion in Q4 2025 and troughed at $30.4 billion in Q3 2022.
  • The 5-year median for Total Debt is $35.1 billion (2023), against an average of $36.4 billion.
  • Year-over-year, Total Debt dropped 7.28% in 2022 and then skyrocketed 40.96% in 2026.
  • A 5-year view of Total Debt shows it stood at $30.7 billion in 2022, then rose by 14.22% to $35.1 billion in 2023, then increased by 5.87% to $37.1 billion in 2024, then soared by 32.95% to $49.3 billion in 2025, then decreased by 0.45% to $49.1 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Total Debt are $49.1 billion (Q1 2026), $49.3 billion (Q4 2025), and $41.4 billion (Q3 2025).